BioGaia AB (publ) (LON:0GTN)

BioGaia AB Statistics

Total Valuation

BioGaia AB has a market cap or net worth of GBP 814.26 million. The enterprise value is 755.57 million.

Market Cap	814.26M
Enterprise Value	755.57M

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	98.50M
Shares Outstanding	n/a
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.20%
Owned by Institutions (%)	45.14%
Float	70.70M

Valuation Ratios

The trailing PE ratio is 32.65 and the forward PE ratio is 25.83.

PE Ratio	32.65
Forward PE	25.83
PS Ratio	7.05
PB Ratio	8.47
P/TBV Ratio	9.66
P/FCF Ratio	31.99
P/OCF Ratio	31.72
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.23, with an EV/FCF ratio of 29.68.

EV / Earnings	30.29
EV / Sales	6.41
EV / EBITDA	21.23
EV / EBIT	20.07
EV / FCF	29.68

Financial Position

The company has a current ratio of 6.27

Current Ratio	6.27
Quick Ratio	4.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	166.59

Financial Efficiency

Return on equity (ROE) is 22.26% and return on invested capital (ROIC) is 20.57%.

Return on Equity (ROE)	22.26%
Return on Assets (ROA)	17.21%
Return on Invested Capital (ROIC)	20.57%
Return on Capital Employed (ROCE)	35.60%
Revenue Per Employee	485,126
Profits Per Employee	104,798
Employee Count	225
Asset Turnover	0.86
Inventory Turnover	n/a

Taxes

In the past 12 months, BioGaia AB has paid 6.81 million in taxes.

Income Tax	6.81M
Effective Tax Rate	21.44%

Stock Price Statistics

The stock price has decreased by -10.18% in the last 52 weeks. The beta is 0.44, so BioGaia AB's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-10.18%
50-Day Moving Average	101.52
200-Day Moving Average	103.41
Relative Strength Index (RSI)	46.12
Average Volume (20 Days)	21,919

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioGaia AB had revenue of GBP 115.46 million and earned 24.94 million in profits. Earnings per share was 0.25.

Revenue	115.46M
Gross Profit	83.95M
Operating Income	36.87M
Pretax Income	31.75M
Net Income	24.94M
EBITDA	34.16M
EBIT	36.87M
Earnings Per Share (EPS)	0.25

Balance Sheet

The company has 57.48 million in cash and n/a in debt, giving a net cash position of 57.48 million.

Cash & Cash Equivalents	57.48M
Total Debt	n/a
Net Cash	57.48M
Net Cash Per Share	n/a
Equity (Book Value)	96.16M
Book Value Per Share	0.95
Working Capital	72.96M

Cash Flow

In the last 12 months, operating cash flow was 25.67 million and capital expenditures -218,063, giving a free cash flow of 25.46 million.

Operating Cash Flow	25.67M
Capital Expenditures	-218,063
Free Cash Flow	25.46M
FCF Per Share	n/a

Margins

Gross margin is 72.71%, with operating and profit margins of 31.93% and 21.60%.

Gross Margin	72.71%
Operating Margin	31.93%
Pretax Margin	27.50%
Profit Margin	21.60%
EBITDA Margin	29.59%
EBIT Margin	31.93%
FCF Margin	22.05%

Dividends & Yields

This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 0.54%.

Dividend Per Share	0.54
Dividend Yield	0.54%
Dividend Growth (YoY)	5.77%
Years of Dividend Growth	1
Payout Ratio	217.52%
Buyback Yield	-0.08%
Shareholder Yield	0.45%
Earnings Yield	3.06%
FCF Yield	3.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.

Last Split Date	May 18, 2022
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	5